Synaptogenix Inc (SNPX)

[Cyosol]

We'll just have to agree to disagree then, because I think you guys are blowing this Memantine washout thing way out of proportion based on a 2% improvement in placebo patients.

From the 2022 paper:

"In the Moderate Stratum Cohort, the imbalance was much smaller, reporting a treatment group difference of 3.8 points in the means and 4 points in medians of baseline SIB scores (mean and median baseline SIB=86.8 and 89.0 in the placebo arm, and a mean and a median baseline SIB=83.0 and 85.0 in the bryostatin arm)."

Placebo patients going from a mean of 87 to 89 after 3 months is not that big of a deal imo.